A Gloucestershire mother is embarking on a grueling challenge to raise funds for vital research into brain tumours, a disease that tragically claimed the life of her husband. Sarah Bennett, from Cheltenham, will undertake a year-long series of physical feats, culminating in a skydive, to support The Brain Tumour Charity.
Brain tumours are a leading cause of cancer death in children and young adults under 40 in the UK. According to The Brain Tumour Charity, they kill more children than any other cancer, and survival rates remain stubbornly low. Sarah’s challenge aims to change that, funding research that could lead to earlier diagnosis and more effective treatments. This story focuses on the personal drive behind this fundraising effort and the broader need for increased awareness and support for brain tumour research.
A Personal Loss Fuels a Determined Effort
Sarah’s husband, David, was diagnosed with a glioblastoma – an aggressive type of brain tumour – in November 2022. He passed away just six months later, leaving Sarah and their two young children devastated. The speed and ferocity of the disease, and the limited treatment options available, spurred Sarah to take action. “It felt so helpless watching David go through it,” she explained to the BBC. “I want to do everything I can to help others avoid the pain our family has gone through.”
Sarah’s challenge, dubbed “David’s Legacy,” began in January with a series of local runs and walks. She has since completed several half-marathons and is currently training for a full marathon in October. Throughout the year, she’ll also be tackling cycling events, hikes, and other physical challenges, building up to the skydive planned for November – the anniversary of David’s diagnosis. As of July 26, 2024, she has already raised over £18,000 for The Brain Tumour Charity.
The Urgent Need for Brain Tumour Research
The Brain Tumour Charity highlights a critical gap in research funding for brain tumours compared to other cancers. While significant progress has been made in treating many types of cancer, survival rates for brain tumours have improved only marginally over the past decades. Their research focuses on understanding the complex biology of brain tumours, developing new diagnostic tools, and identifying more effective therapies.
One of the major challenges in treating brain tumours is their heterogeneity – meaning that no two tumours are exactly alike. This makes it difficult to develop treatments that work for everyone. Researchers are also working to overcome the blood-brain barrier, a protective mechanism that prevents many drugs from reaching the tumour. Funding from initiatives like Sarah’s challenge is crucial to accelerating these research efforts.
Understanding Glioblastoma
David Bennett’s diagnosis of glioblastoma is particularly significant, as We see the most common and aggressive type of malignant brain tumour in adults. The National Brain Tumor Society notes that glioblastoma has a median survival time of just 15-18 months, even with the standard of care treatment, which includes surgery, radiation, and chemotherapy.
The difficulty in treating glioblastoma stems from its rapid growth, its ability to invade surrounding brain tissue, and its resistance to conventional therapies. Researchers are exploring new approaches, including immunotherapy, targeted therapies, and gene therapy, but these are still in the early stages of development.
How to Support Sarah’s Challenge and Brain Tumour Research
Sarah’s fundraising page can be found on JustGiving: https://www.justgiving.com/page/sarah-bennett-davidslegacy. Donations of any size are gratefully accepted and will directly support The Brain Tumour Charity’s research programs.
Beyond financial contributions, raising awareness about brain tumours is also vital. The Brain Tumour Charity provides a wealth of information about the disease, its symptoms, and available support resources on their website. Sharing information and encouraging others to learn more can help to improve early diagnosis and access to care.
The charity also encourages people to contact their local Member of Parliament to advocate for increased funding for brain tumour research. Increased investment in research is essential to improving outcomes for those affected by this devastating disease.
Sarah’s skydive is scheduled for November 2024, marking a year since David’s initial diagnosis. She hopes her efforts will not only raise funds but also inspire others to support the fight against brain tumours. The next update on Sarah’s progress and fundraising total will be available on her JustGiving page.
If you’ve been affected by the issues raised in this article, or would like to learn more about brain tumours, please consider visiting The Brain Tumour Charity’s website.
Share this story to help raise awareness and support vital research into brain tumours. Your contribution, no matter how small, can develop a difference.
Keep reading
